These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7848515)

  • 21. Challenges and opportunities for monoclonal antibody therapy in veterinary oncology.
    Beirão BC; Raposo T; Jain S; Hupp T; Argyle DJ
    Vet J; 2016 Dec; 218():40-50. PubMed ID: 27938708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant antibodies as therapeutic agents: pathways for modeling new biodrugs.
    Aires da Silva F; Corte-Real S; Goncalves J
    BioDrugs; 2008; 22(5):301-14. PubMed ID: 18778112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant toxins for the treatment of cancer.
    Kreitman RJ
    Curr Opin Mol Ther; 2003 Feb; 5(1):44-51. PubMed ID: 12669470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the applications of monoclonal antibodies in clinical oncology. Proceedings of the 5th international meeting. London, UK, 25-27 May 1988.
    Int J Cancer Suppl; 1988; 3():1-103. PubMed ID: 3209294
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic monoclonal antibodies in clinical neurology].
    Buttmann M; Wiendl H
    Nervenarzt; 2010 Jun; 81(6):753-64; quiz 765-6. PubMed ID: 20232033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific targeting of cancer with monoclonal antibodies: diagnostic and therapeutic applications.
    Abrams PG; Morgan AC; Fritzberg R
    Cancer Invest; 1990; 8(2):287-8. PubMed ID: 2400950
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antitumor immunotherapy].
    Błoński JZ; Warzocha K
    Postepy Hig Med Dosw; 1994; 48(6):701-28. PubMed ID: 7675731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical uses of monoclonal antibodies in cancer research.
    Moldawer NP; Murray JL
    Cancer Nurs; 1985 Aug; 8(4):207-13. PubMed ID: 3850786
    [No Abstract]   [Full Text] [Related]  

  • 29. The Monoclonal Antibody Program of the Cuban Institute of Oncology and Radiobiology.
    Lage A
    Eksp Onkol; 1990; 12(6):26-30, 64. PubMed ID: 1702051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Present status of studies on the application of immunology to the diagnosis and therapy of cancer, with emphasis on monoclonal antibodies and cytokines].
    Tokunaga T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1358-66. PubMed ID: 3296954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody engineering: facing new challenges in cancer therapy.
    Sanz L; Cuesta AM; Compte M; Alvarez-Vallina L
    Acta Pharmacol Sin; 2005 Jun; 26(6):641-8. PubMed ID: 15916728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research and development of therapeutic mAbs: An analysis based on pipeline projects.
    Geng X; Kong X; Hu H; Chen J; Yang F; Liang H; Chen X; Hu Y
    Hum Vaccin Immunother; 2015; 11(12):2769-76. PubMed ID: 26211701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies (MAb) in clinical oncology.
    Bosslet K; Sedlacek HH
    Behring Inst Mitt; 1986 Jun; (80):42-7. PubMed ID: 2428351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design.
    Deyev SM; Lebedenko EN
    Bioessays; 2008 Sep; 30(9):904-18. PubMed ID: 18693269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Side effects of monoclonal antibodies in diagnostic and therapeutic applications in cancer].
    van der Linden EF; van Kroonenburgh MJ
    Ned Tijdschr Geneeskd; 1988 Nov; 132(45):2049-52. PubMed ID: 3054580
    [No Abstract]   [Full Text] [Related]  

  • 36. Bi-specific antibody therapy for the treatment of cancer.
    Withoff S; Helfrich W; de Leij LF; Molema G
    Curr Opin Mol Ther; 2001 Feb; 3(1):53-62. PubMed ID: 11249732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Implications of receptors for the Fc portion of IgG (FcgammaRs) in mechanism of action of therapeutic antibodies].
    Lejeune J; Thibault G; Cartron G; Ohresser M; Watier H
    Bull Cancer; 2010 May; 97(5):511-22. PubMed ID: 20371423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humanized antibodies as potential drugs for therapeutic use.
    Merluzzi S; Figini M; Colombatti A; Canevari S; Pucillo C
    Adv Clin Path; 2000 Apr; 4(2):77-85. PubMed ID: 11080787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies as therapeutic agents in oncology and antibody gene therapy.
    Zhang Q; Chen G; Liu X; Qian Q
    Cell Res; 2007 Feb; 17(2):89-99. PubMed ID: 17242688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies: clinical applications.
    Reckel R
    Adv Clin Chem; 1989; 27():355-415. PubMed ID: 2667295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.